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Abstract
Peripheral blood mononuclear cells from leprosy patients underwent spontaneous apoptosis upon culture for 24 h. The
apoptosis was inhibited by anti-TNFK antibodies and to a certain extent by anti-IL-1K and IL-6, thus showing that TH2-type
cytokines (mainly TNFK) are responsible for inducing apoptosis. This cytokine-mediated apoptosis could be inhibited by
ionomycin and zinc, thereby suggesting that these metal ions can be used to decrease the levels of these inflammatory cytokines
in various diseases. z 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Apoptosis plays a crucial role in the pathogenesis
of disease [1,2] and can be induced in the cells by
activation of certain death molecules such as TNFK
or fas [3,4]. In diseased conditions, it can occur due
to interference of the pathogens with the intracellular
signaling pathway [5]. This may lead to apoptosis in
response to TCR-mediated expression of CD95
[6^8], or making T-cells sensitive to CD95 ligation.
Anergy is thought to be closely linked to apoptosis
[9]. Leprosy, like other intracellular pathogens, is
associated with impairment of CMI response leading
to unresponsiveness or anergy in lepromatous lep-
rosy patients [10,11]. The anergic state also occurs
due to an imbalance in signaling, i.e. when T-cells
are stimulated via TCR complex alone and activa-
tion through co-stimulatory molecules (i.e. CD28)
does not occur [12]. Leprosy exhibits a clear-cut im-
munological polarity between tuberculoid and lep-
romatous leprosy showing a TH1- and TH2-type re-
sponse, respectively [11,13]. The TH2-type cytokines
are responsible for inducing/maintaining anergic
state in the cells. IL-10 is well known to be a down-
regulator of co-stimulatory molecules, e.g. B-7
[14,15]. The antibodies to IL-4 and IL-10 can restore
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proliferation in HIV and other human infections
showing that these cytokines exert suppressive e¡ect
on the cell proliferation [16^18]. It is speculated that
the activation of these anergic cells may lead to an
imbalance in signaling resulting in their apoptosis.
High levels of these cytokines have also been
shown to induce apoptosis in PBMCs of HIV pa-
tients [19,20]. As the levels of TH2 cytokines (IL-4,
IL-6, IL-10) and certain proin£ammatory cytokines
such as TNFK, IL-1 and IL-6 are known to increase
in reactional states in leprosy [11,21], so an attempt
was made to study the role of these cytokines in
inducing apoptosis in PBMCs of these patients.
2. Materials and methods
Untreated patients visiting the leprosy clinic of
Nehru Hospital attached to the Postgraduate Insti-
tute of Medical Education and Research, Chandi-
garh were enroled in the study. Patients were classi-
¢ed according to the Ridley and Jopling [22]
classi¢cation for leprosy. Slit skin smear and skin
biopsy was carried out in all patients to con¢rm
the diagnosis. Controls were healthy laboratory per-
sonnel on no type of medication.
2.1. Isolation of PBMCs
Venous blood (5 ml) was withdrawn from patients
in vials containing heparin after obtaining informed
consent. The peripheral blood mononuclear cells
were isolated by layering the blood on ¢coll-paque
[23]. After centrifugation at 400Ug for 30 min, the
bu¡y coat was taken out washed twice with RPMI
1640 and cells were suspended in RPMI 1640 me-
dium supplemented with 2 mM L-glutamine, 100
units ml31 benzylpenicillin, 100 Wg ml31 streptomy-
cin and containing 10% fetal calf serum. The cells
were cultured in 96-well £at- bottom culture plates
in the humidi¢ed CO2 chamber at 37‡C.
2.2. Quantitation of apoptosis
Apoptosis was quantitated by staining nuclei with
propidium iodide (PI) and analyzing £uorescence
with FACScan (Becton Dickinson, USA) as de-
scribed by Gouegeon et al. [24]. Brie£y, following
culture for 24 h, cells were collected after centrifuga-
tion at 200Ug for 10 min. The pellet was gently
suspended in 0.5 ml of hypotonic £uorochrome sol-
ution (0.1% sodium citrate with 0.1% Triton X-100)
containing 20 Wg per ml PI for 20 min. RNase A at a
concentration of 10 Wg ml31 was added and cells
were further incubated for 10 min at 4‡C. The sus-
pension was analyzed by £ow cytometry to deter-
mine PI £uorescence of individual nuclei. Apoptotic
nuclei appeared as a broad hypodiploid DNA peak
that was easily discriminated from narrow peak of
nuclei with normal (diploid) DNA content. The per-
centage of cells undergoing apoptosis was taken for
calculation of mean þ S.E.M. Student’s t-test was
used for statistical analysis of data.
Anti-TNFK, IL-4, IL-6, IL-1K cytokine antibodies
(Amersham, UK) at a concentration of 5 Wg ml31,
ionomycin (Sigma, USA) at a concentration of 200
ng ml31, zinc (5 mM) and leupeptin (50 WM) were
added to the cells and checked for apoptosis after 24
h. The concentrations used were not toxic for normal
cells as measured by apoptosis and Trypan blue
staining. The apoptosis was also measured by incu-
bating the cells with TNFK (500 pg ml31), IL-6 (50
pg ml31), rIL-2 (40 units ml31) (a gift from NCI,
Bethesda, MD), concanavalin A (10 Wg ml31) and
anti-TCR K/L antibodies (1 Wg), which were coated
on the 96-well culture plates.
2.3. Expression of co-stimulatory molecules
Cells were stained with monoclonal antibodies ob-
tained from Becton Dickinson, Monoclonal Center,
California, USA. The monoclonal antibodies were
directed against the cell surface antigens CD28,
ICAM-1 and B-7. CD28 was conjugated to phycoer-
ythrin while for ICAM-1 and B-7, the cells were ¢rst
stained with primary monoclonal antibody followed
by secondary antibody conjugate to FITC.
Brie£y, 100 Wl of whole blood was incubated with
10 Wl of PE- conjugated or unconjugated primary
antibody for 20^30 min at room temperature. This
was followed by addition of FACS lysing solution
(Becton Dickinson) and further incubated for 10
min. For B-7 and ICAM-1, cells were further incu-
bated with secondary FITC conjugate after washing
with PBS. Appropriate isotype controls were also
used.
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3. Results
PBMCs of leprosy patients showed a decrease in
expression of co-stimulatory molecules CD28 and B-
7. The mean £uorescence intensity for CD28 was
102.71 þ 38.71 and 220.39 þ 13.93 for B-7 in BL/LL
patients (P6 0.001) (Table 1) and was V2-fold less
when compared to healthy controls thus suggesting
that lack of co-stimulatory molecules leads to an
anergic state in the T-cells of these patients.
To study the mechanism of anergy, the cells were
cultured in the presence of anti-TCR K/L antibodies
coated onto 96-well plates, and another mitogen,
concanavalin A. However, we found that cells under-
went spontaneous apoptosis in in vitro conditions
and the apoptosis was enhanced on incubation
with Con A (BT/TT, 41.16 þ 8.05; BL/LL,
47.5 þ 7.03) and anti-TCR K/L (BT/TT, 38.2 þ 6.38;
BL/LL, 47.78 þ 3.68) antibodies (Table 2).
In order to understand the mechanism of apopto-
sis, the cells were incubated with a number of known
inhibitors of apoptosis like leupeptin, ionomycin,
zinc, N-ethyl-maleimide and cyclosporin A. The ion-
omycin, zinc and leupeptin were able to inhibit apop-
tosis by V45% and zinc was more e⁄cient in block-
ing apoptosis, especially in patients with reaction
and inhibition was almost V55% in case of BL/LL
without reaction (16.77 þ 4.92; P6 0.01) and by
V60% in patients with reaction (22.75 þ 13.47;
P6 0.02) (Table 3).
Leupeptin (which is a non-speci¢c inhibitor of cys-
teine proteases) was used to inhibit apoptosis result-
ing through certain cysteine proteases called casp-
ases. Leupeptin, being non-speci¢c, could inhibit
apoptosis up to V60% (P6 0.001), thus showing
the involvement of cysteine proteases. It has already
been reported that leupeptin can inhibit apoptosis
only by V60% in cells.
Since, apoptosis was inhibited signi¢cantly in ENL
patients, and these patients have high levels of IL-
1K, IL-4, IL-6 and TNFK, so the antibodies against
these cytokines were used to study whether these
TH2-type cytokines play any role in inducing apop-
tosis. After 24 h of culture in presence of these anti-
bodies, the TNFK could inhibit apoptosis in ENL
patients by 65% (P6 0.001 for patients with reac-
tion; P6 0.01 for patients without reaction), where-
as IL-1K, IL-4 and IL-6 inhibited apoptosis in ENL
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Table 2
Percent apoptosis in PBMCs of leprosy patients in the presence of mitogens
Patients Spontaneous apoptosis Con A Anti-TCR K/L
Control (n = 8) 8.25 þ 2.88 8.00 þ 3.25 9.75 þ 2.68
BT/TT (n = 6) 25.00 þ 5.81a;* 41.16 þ 8.05a;** 38.20 þ 6.38a;*
BL/LL (n = 14) 37.78 þ 7.6a;** 47.50 þ 7.03a;** 47.78 þ 3.68a;**
Values represent mean þ S.E.M.
avs. control (spontaneous apoptosis of the same patient group.
*P6 0.05.
**P6 0.02.
Table 1
Expression of co-stimulatory molecules on the surface of PBMCs of leprosy patients
Patients CD28 B-7 ICAM-1
Control (n=10) 362.46 þ 46.62 415.62 þ 62.21 222.40 þ 52.24
BT/TT (n=10) 251.20 þ 62.40a;* 387.40 þ 58.24a;*** 182.20 þ 20.48a;*
BL/LL (n=10) 102.71 þ 38.71b;** 220.39 þ 13.93b;** 60.00 þ 40.20b;**
Values represent mean þ S.E.M. of relative £uorescence.
aBT/TT vs. control.
bBL/LL vs. control.
*P6 0.02.
**P6 0.001.
***P6 0.05.
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patients only (Fig. 1) and this inhibition was about
V30% (P6 0.01), thus suggesting that TH2-type cy-
tokines lead to induction of apoptosis in these pa-
tients.
The incubation of cells with IL-1K, IL-4, IL-6 and
TNFK led to an enhanced cell death in PBMCs of
these patients (Table 4). Since, IL-2 is known to have
protective e¡ect against apoptosis and anergic cells
do not produce IL-2, so the cells were incubated in
the presence of rIL-2 and it inhibited apoptosis by
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Fig. 1. E¡ect of various anticytokine antibodies on inhibition of apoptosis in leprosy patients without reaction (left) and with reaction
(right). Values represent mean þ S.E.M. (n = 5).
Table 3
Percent apoptosis in PBMCs of leprosy patients in the presence of various inhibitors
Patients Spontaneous Ionomycin apoptosis Zinc Leupeptin
Controls (n = 8) 7.47 þ 1.48 8.00 þ 1.24 7.90 þ 0.88 7.20 þ 0.78
BT/TT (n = 6) 27.66 þ 8.88 19.66 þ 6.76 17.42 þ 5.72b;* 16.28 þ 4.54
BT/TT in reaction (n = 5) 36.54 þ 3.60a;* 17.42 þ 4.9b;* 14.23 þ 5.47b;** 15.42 þ 5.20b;**
BL/LL (n = 9) 33.66 þ 9.09a;*** 19.55 þ 5.46b;*** 16.77 þ 4.92b;*** 18.42 þ 2.40b;3
BL/LL (type II reaction; n = 5) 48.50 þ 14.68a;3 37.50 þ 9.9b;* 22.75 þ 13.47b;** 24.28 þ 3.70b;3
Values represent mean þ S.E.M.
avs. control (spontaneous).
bvs. spontaneous apoptosis of the same group.
*P6 0.05.
**P6 0.02.
***P6 0.01.
3P6 0.001.
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V45% (P6 0.02), suggesting that apoptosis in these
patients occurs due to an increase in TH2 cytokines
and a decrease in TH1 cytokines.
4. Discussion
Two signals are required for normal proliferation
of cells. One is mediated through TCR and another
through co-stimulatory molecules such as CD28. If
there is an imbalance in these signals, then the cells
undergo anergy and/or apoptosis [25]. Our results
show that in leprosy patients, the co-stimulatory
molecules such as CD28, B-7 and adhesion molecules
(ICAM-1) which play an important role in activation
of T-cells, are down regulated. As a result, when cells
are stimulated (with various mitogens), in the ab-
sence of co-stimulatory signals, they undergo apop-
tosis, which could be the cause of anergy in leprosy.
In acute herpes virus infection (AHVI) and chronic
HIV patients it has been shown that CD283 popu-
lation fail to respond normally to activation signals
through TCR and are prone to activation induced
cell death (AICD). CD28 is required for IL-2 pro-
duction and enhances the levels of bclxL and bcl-2 to
prevent apoptosis [26].
Besides co-stimulatory molecules, the PBMCs of
leprosy patients are also defective in calcium mobil-
ization as the ionomycin could inhibit the apoptosis
in these cells. Our previous ¢ndings have also shown
that cells of leprosy patients are defective in proxi-
mal signal transduction pathway [27]. A perturbation
of intracellular calcium homeostasis is well known to
trigger apoptosis and it may occur either due to a
sustained increase in cytosolic free calcium levels or a
depletion of intracellular calcium stores [25,28]. Fur-
ther a recent report has shown that TH2-type cells
fail to use calcium signaling pathway [29]. Since, cal-
cium plays an important role in synthesis of IL-2,
thus ionomycin might be increasing the availability
of calcium for initiation of distal TCR-mediated sig-
nal transduction pathway.
The apoptosis in PBMCs of leprosy patients was
also inhibited by zinc (which is known to block
Ca2-dependent apoptosis by blocking calcium/mag-
nesium endonuclease activity) [30] and was more ef-
fective than ionomycin, especially in cells from ENL
patients. Zinc has been shown to inhibit apoptosis by
lowering TNFK levels and increasing IL-2 in case of
ENL patients (Gupta et al. 1998, communicated),
although the exact mechanism of action is not
known as yet. This is supported by the earlier reports
which show that the serum of leprosy patients is
de¢cient in calcium, iron, magnesium and zinc [31^
34] and oral zinc therapy decreases the chances of
reactions in these patients.
Thus, our study shows that anergy in leprosy pa-
tients is due to multiple defects in the TCR-mediated
signaling i.e., defective calcium mobilization, zinc de-
¢ciency and lack of expression of co-stimulatory
molecules. The absence of these signals could be re-
sponsible for an established TH2-type response in
lepromatous leprosy patients. These TH2-type cyto-
kines may lead to an increase in susceptibility of cells
to undergo apoptosis. In the case of patients with
reaction, anti-cytokine antibodies blocked apoptosis,
further con¢rming that these cytokines are responsi-
ble for inducing apoptosis in these cells. rIL-2 was
also able to block apoptosis indicating that cells are
de¢cient in IL-2 and this incapability to produce IL-
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Table 4
Percent apoptosis in PBMCs of leprosy patients in the presence of various cytokines
Patients Spontaneous rIL-2 rIL-4 rIL-6 rIL-1K TNFK
Control (n = 7) 8.24 þ 2.88 7.84 þ 3.25 8.41 þ 2.5 7.25 þ 3.99 6.40 þ 2.17 7.20 þ 2.68
BT/TT (n = 8) 25.00 þ 5.81 19.00 þ 4.15 21.50 þ 3.41 25.42 þ 5.22 22.80 þ 4.37 33.00 þ 2.45
BL/LL (n = 8) 37.20 þ 9.4 15.74 þ 2.47a;* 58.88 þ 4.52a;** 52.54 þ 3.56a;** 49.20 þ 2.78a;* 60.24 þ 3.89a;***
BL/LL with reaction (n = 5) 46.88 þ 10.4 25.66 þ 8.2a;* 70.60 þ 9.4a;** 68.00 þ 8.35a;** 65.23 þ 10.45a;** 80.00 þ 4.58a;***
Values represent mean þ S.E.M.
avs. spontaneous apoptosis of the same group.
*P6 0.02.
**P6 0.01.
***P6 0.001.
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2 (due to defective/insu⁄cient signaling) may lead to
anergy and/or apoptosis. Since, TNFK is well known
to activate cysteine proteases (caspases), so the inhib-
ition of apoptosis by leupeptin (a non-speci¢c cys-
teine protease inhibitor) also shows the mechanism
of action of TNFK could be through cysteine pro-
teases.
To summarize, our results clearly show that cells
of leprosy patients are anergic and defective in prox-
imal TCR-mediated signal transduction pathway,
leading to a perturbation in the intracellular second
messengers. This leads to an imbalance in signal
transduction pathway which may lead to a transition
from TH1- to TH2-type phenotype and the overpro-
duction of the TH2-type and certain proin£amma-
tory cytokines, thereby causing apoptosis in these
cells. This TNFK-mediated e¡ect can be blocked,
to a certain extent, by ionomycin and zinc, thus
showing that these metal ions can help in improving
the CMI response in these patients especially in the
case of ENL patients and in certain other in£amma-
tory diseases.
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